NCT Number: NCT03821246
Phase: Phase 2
Trial Summary: This phase II trial studies how well atezolizumab works alone or in combination with etrumadenant or tocilizumab in treating men with localized prostate cancer before radical prost – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s):
Acronym:
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives